Skip to main content

Advertisement

Log in

Association Between Underlying Comorbid Conditions and Stage of Presentation in Cutaneous Melanoma

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Paulson KG, Gupta D, Kim TS, et al. Age-specific incidence of melanoma in the United States. JAMA Dermatol. Jan 2020;156(1):57–64. https://doi.org/10.1001/jamadermatol.2019.3353.

    Article  PubMed  Google Scholar 

  2. Gurney J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at diagnosis. Br J Cancer. Nov 2015;113(9):1375–80. https://doi.org/10.1038/bjc.2015.355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Grann AF, Frøslev T, Olesen AB, Schmidt H, Lash TL. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study. Br J Cancer. Jul 2013;109(1):265–71. https://doi.org/10.1038/bjc.2013.246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. The American College of Surgeons. About the National Cancer Database. National Cancer Database. https://www.facs.org/quality-programs/cancer/ncdb/about. Accessed 7 Oct 2020.

  5. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–9. https://doi.org/10.1016/0895-4356(92)90133-8.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No sources of funding were used to assist in the preparation of this article.

Author information

Authors and Affiliations

Authors

Contributions

RJS, JCT, CES, EYC, JTM, GCK: Substantial contributions to the conception and design of the study, acquisition of data, and analysis and interpretation of the data. RJS, JCT, CES, EYC, JTM, GCK: Drafting the article or revising it critically for important intellectual content. RJS, JCT, CES, EYC, JTM, GCK: Final approval of the version to be published. All authors have reviewed and approved the submitted manuscript and agree to be accountable for all aspects of the work submitted.

Corresponding author

Correspondence to Richard J. Straker III MD.

Ethics declarations

Disclosures

Richard J. Straker III, Jerica C. Tidwell, Cimarron E. Sharon, Emily Y. Chu, John T. Miura, and Giorgos C. Karakousis have no conflicts of interest to declare. This study was presented as a Quickshot presentation at the 17th Annual Academic Surgical Congress, 1–3 February 2022, in Orlando, FL, USA.

Ethical approval

Institutional Review Board approval Exempt.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Richard J. Straker III and Jerica C. Tidwell contributed equally to this study as first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Straker, R.J., Tidwell, J.C., Sharon, C.E. et al. Association Between Underlying Comorbid Conditions and Stage of Presentation in Cutaneous Melanoma. Ann Surg Oncol 29, 4052–4056 (2022). https://doi.org/10.1245/s10434-022-11547-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11547-8

Navigation